549547-33-3

Basic information

• Product Name: 4-(4-chlorophenoxy)-3,5-difluoroaniline
• Synonyms: Benzenamine, 4-(4-chlorophenoxy)-3,5-difluoro-
• CAS NO: 549547-33-3
• Molecular Formula: C₁₂H₈ClF₂NO
• Molecular Weight: 255.6478264
• Mol File: 549547-33-3.mol

Chemical Properties

• Boiling Point: 309.3±42.0 °C(Predicted)
• Appearance: /
• Density: 1.399±0.06 g/cm3(Predicted)
• PKA: 2.57±0.10(Predicted)
• CAS DataBase Reference: 4-(4-chlorophenoxy)-3,5-difluoroaniline(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-chlorophenoxy)-3,5-difluoroaniline(549547-33-3)
• EPA Substance Registry System: 4-(4-chlorophenoxy)-3,5-difluoroaniline(549547-33-3)

Safety Data

• Hazardous Substances Data: 549547-33-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical and Agrochemical Synthesis:
4-(4-chlorophenoxy)-3,5-difluoroaniline is used as a key intermediate in the synthesis of various pharmaceuticals and agrochemicals, contributing to the development of new drugs and pesticides due to its unique chemical structure and properties.
Used in Dye and Pigment Production:
In the dye and pigment industry, 4-(4-chlorophenoxy)-3,5-difluoroaniline is utilized as a precursor for the production of dyes and pigments, offering a range of color options and enhancing the performance of these products.
Used as an Insecticide in Agriculture:
4-(4-chlorophenoxy)-3,5-difluoroaniline is employed as an insecticide in the agricultural industry, providing effective pest control and protecting crops from insect damage. Its insecticidal properties make it a valuable tool in maintaining crop yields and quality.
However, due to potential environmental and health hazards associated with 4-(4-chlorophenoxy)-3,5-difluoroaniline, strict regulations and safety precautions are necessary in its handling and use to minimize risks and ensure sustainable practices.

Upstream product

• 549547-32-2 4-(4-chlorophenoxy)-3,5-difluoronitrobenzene 
• 7439-89-6 iron 
• 66684-58-0 3,4,5-trifluoronitrobenzene 
• 106-48-9 4-chloro-phenol 

Relevant articles and documents

Methods of Treating Aneurysmal Dilatation, Blood Vessel Wall Weakness and Specifically Abdominal Aortic and Thoracic Aneurysm Using Matrix Metalloprotease-2 Inhibitors

The present invention provides methods of treating aneurysmal dilatation, blood vessel wall weakness, and specifically abdominal aortic aneurysm and thoracic aneurysm by inhibiting MMPs and ADAM-10. Such compounds are useful in the in vitro study of the r

HUMAN ADAM-10 INHIBITORS

The present invention provides compounds useful for inhibiting the ADAM-10 protein, with selectivity versus MMP-1. Such compounds are useful in the in vitro study of the role of ADAM-10 (and its inhibition) in biological processes. The present invention also comprises pharmaceutical compositions comprising one or more ADAM-10 inhibitors according to the invention in combination with a pharmaceutically acceptable carrier. Such compositions are useful for the treatment of cancer, arthritis, and diseases related to angiogenesis. Correspondingly, the invention also comprises methods of treating forms of cancer, arthritis, and diseases related to angiogenesis in which ADAM-10 plays a critical role.